Independent Trial Results Released For Its AccutasVET Tapeworm Fecal Test
November 15, 2017 - Aquila Diagnostic Systems Inc. (“Aquila”) is pleased to announce results of an independent laboratory trial for its point-of-care AccutasVET DNA Tapeworm fecal test based on Aquila’s patented molecular diagnostics hydrogel technology.
The independent study demonstrated that the diagnostic performance characteristics of the AccutasVET Tapeworm fecal test are clinically significant ...